ImmunityBio shot considered as booster in South Africa Covid study

ImmunityBio Inc’s hAd5 T-cell Covid-19 vaccine candidate is being considered as a booster shot in a study of almost 500,000 South African health workers who have received Johnson & Johnson’s inoculation. Source: BusinessTech